Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

238
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
238
Bipolar Disorder01:30

Bipolar Disorder

106
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
106
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

166
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
166
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

69
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
69
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

328
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
328
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

15
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
15

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Probiotics in reducing negative symptoms of schizophrenia: A systematic review and meta-analysis.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Towards an Integrated Staging Model for Bipolar Disorders: An International Society for Bipolar Disorders (ISBD) Staging Task Force Consensus Report.

Bipolar disorders·2026
Same author

Prevalence, Severity and Correlates of Post-traumatic Stress Disorder in 205 Outpatients with Schizophrenia: Results from a Cross-sectional, Observational Study Assessing Diagnoses via the Mini-International Neuropsychiatric Interview.

CNS spectrums·2026
Same author

Ketamine and esketamine for the prevention of postpartum depression: A systematic review and network meta-analysis, with an integrated evidence synthesis.

Psychiatry research·2026
Same author

Shared decision-making in mood disorders: when guidelines omit what patients most want to know.

Journal of affective disorders·2026
Same author

Vertex (Buenos Aires, Argentina)·2026
Same journal

Vertex (Buenos Aires, Argentina)·2026
Same journal

Vertex (Buenos Aires, Argentina)·2026
Same journal

Vertex (Buenos Aires, Argentina)·2026
Same journal

Vertex (Buenos Aires, Argentina)·2026
Same journal

Vertex (Buenos Aires, Argentina)·2026
Same journal

Vertex (Buenos Aires, Argentina)·2026
See all related articles

Related Experiment Video

Updated: Jul 19, 2025

Developing a Rat Model for Bipolar Disorder
04:44

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

343

Third Argentine Consensus statement on management Bipolar Disorders. Section 2 B

Marcelo Cetkovich-Bakmas1, Andrea Abadi2, Sebastián Camino3

  • 1Investigador del Instituto de Neurociencias Cognitivas y Traslacionales (INCYT), CONICET-Fundación INECO-Universidad Favaloro. Buenos Aires, Argentina. alejocorrales@hotmail.com.

Vertex (Buenos Aires, Argentina)
|August 10, 2023
PubMed
Summary
This summary is machine-generated.

This consensus provides updated evidence-based therapeutic recommendations for managing bipolar disorders in adults. It covers acute mania, bipolar depression, mixed states, suicidality, and psychological interventions, including side effect management.

Keywords:
Bipolar disordersEvidence base guidelinesExperts consensusMood stabilizersAntidepressantsAntipsychotics

More Related Videos

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.3K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

726

Related Experiment Videos

Last Updated: Jul 19, 2025

Developing a Rat Model for Bipolar Disorder
04:44

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

343
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.3K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

726

Area of Science:

  • Psychiatry
  • Pharmacology
  • Psychotherapy

Context:

  • The Third Argentine Consensus on the Management of Bipolar Disorders presents updated evidence for adult patient care.
  • This section focuses on therapeutic strategies for various bipolar disorder states.

Purpose:

  • To synthesize current evidence on managing bipolar disorders in adults.
  • To offer therapeutic recommendations for acute mania, bipolar depression, mixed states, and suicidality.
  • To outline the assessment and management of pharmacotherapeutic side effects.

Summary:

  • This document details evidence-based treatment approaches for adult bipolar disorder.
  • Recommendations encompass pharmacotherapy and psychological interventions for mania, depression, and mixed states.
  • Management of treatment-related side effects is also addressed.

Impact:

  • Provides clinicians with updated guidelines for effective bipolar disorder management.
  • Aims to improve patient outcomes through optimized therapeutic strategies.
  • Contributes to the advancement of bipolar disorder treatment protocols.